Advanced Clinical Safety Testing (HRIPT)
Human Repeat Insult Patch Testing with Board-Certified Dermatologist Sign-Off
Administered with n = 50 human subjects under board-certified dermatological supervision following Good Clinical Practice (GCP) protocols across induction, rest, and challenge phases. Required for formal clinical labeling claims, export clearance to the EU and US, and product liability protection.
• Certified Dermatological Clinical Study Report
• Individual Subject Reaction Scorecards (n = 50)
• Formal Dermatologist Safety Sign-Off Certificate
• Legal Claim Unlocking Dossier: 'Dermatologist Tested', 'Clinically Proven Safe', 'Hypoallergenic'
R 170,000.00 Project Dependent
Brands making medical marketing claims, products for sensitive/atopic skin, infant skincare, luxury dermatological cosmetics.
Protects brand against product liability lawsuits; legally unlocks claims: 'Dermatologist Tested,' 'Clinically Proven Safe,' 'Hypoallergenic.'